David Iglesias, MD - Research

Research at a glance

Top areas of exploration

Endometrial Neoplasms , 9 publications
Metformin , 5 publications
Uterine Neoplasms , 4 publications
Carcinoma, Endometrioid , 4 publications

Research activity

24 publications

934 citations

Why is this important?

Active clinical trials

Comparing Two Surgical Procedures in Individuals with Ovarian Cancer+BRCA1 Mutations(SOROCk)

This clinical trial evaluates how well two surgical procedures (bilateral salpingectomy and bilateral salpingo-oophorectomy) work in reducing the risk of ovarian cancer for individuals with BRCA1 mutations. Bilateral salpingectomy involves the鈥�

Investigator: David Iglesias
Status: Accepting Candidates
Ages: 35 Years - 50 Years
Sexes: Female

My publications

24 publications

2025

Tumor Treating Fields therapy in platinum-resistant ovarian cancer: Results of the ENGOT-ov50/GOG-3029/INNOVATE-3 pivotal phase 3 randomized study.

European journal of cancer (Oxford, England : 1990)

鈥�

2023

Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.

The New England journal of medicine

鈥�

2023

Dysgerminoma Masquerading as Gestational Trophoblastic Neoplasia.

Case reports in obstetrics and gynecology

鈥�

2022

Adjuvant therapy in women with early stage uterine serous carcinoma: A multi-institutional study.

Gynecologic oncology

鈥�

2022

Endometrial Cancer Characteristics and Risk of Recurrence.

American journal of clinical pathology

鈥�

BOB体育